EUROPEAN TRAINING CENTRES
Wroclaw
Wroclaw Medical University
Department of Nephrology and Transplantation Medicine,
Wroclaw Medical University
Wroclaw, Poland

 

Peer Reviewed Publications in International Journals (only English) 2000-2005

Publications List 2003-2005

• Jezior D., Boratynska M., Halon A., Kusztal M., Rabczynski J., Szyber P., Patrzalek D., Kaminska D., Klinger M..Biopsy eosinophilia as a predictor of renal graft dysfunction. Transplant. Proc.,2003,35;2182
• Kaminska D., Tyran B., Mazanowska O., Kochman A., Rabczynski J., Szyber P., Patrzalek D.,  Chudoba P.,  Klinger M.. Cytokine gene expression in kidney allograft donor biopsies after cold ischemia and reperfusion using in situ RT-PCR analysis. Transplant. Proc.2003,35;2155
• Wrobel A., Kaminska D., Klinger M..Electron paramagnetic resonance study of erythrocyte membrane fluidity in renal transplant recipients.Transplant. Proc.,2003,35; 2230
• Boratynska M., Radwan-Oczko M., Falkiewicz K., Klinger M.,  Szyber P.Gingival overgrowth in kidney transplant recipients treated with cyclosporine and its relationship with chronic graft nephropathy.Transplant. Proc.,2003,35;2238
• Kuriata-Kordek M., Boratynska M., Falkiewicz K.,  Porazko T., Urbaniak J., Wozniak M., Patrzalek D., Szyber P., Klinger M.. The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics. Transplant. Proc., 2003,35;2369
• Boratynska M., Banasik M., Watorek E., Klinger M., Dorobisz A., Szyber P.. Influence of hypercholesterolemia and acute graft rejection on chronic nephropathy development in renal transplant recipients Transplant. Proc.,2003,35;2209
• Zmonarski S., Boratynska M., Madziarska K., Klinger M.,  Kusztal M., Patrzalek, D., Szyber P. Mycophenolate mofetil severely depresses antibody response to CMV infection in early posttransplant period. Transplant. Proc., 2003,35; 2205
• Falkiewicz K., Nahaczewska W., Boratynska M., Owczarek H., Klinger M.,  Kaminska D., Wozniak M.,  Szepietowski T., Patrzalek D. Tacrolimus decreases tubular phosphate wasting in renal allograft recipients. Transplant. Proc., 2003,35;2213
• Grabowski K., Kusztal M.Long-term quality of life and symptoms of patients who underwent esophageal reconstruction employing intestinal pedicle grafts. Am. J. Surg. 2004,187;422
• Weyde W., Krajewska M., Penar J., Bartosik H., Klinger M. Vascular abnormalities in patients with autosomal dominant polycystic kidney disease - the influence on arteriovenous fistula creation. Clin. Nephrol., 2004,61;344
• Jadoul M., Poignet J.-L., Geddes C., Locatelli F.,  Medin C.,  Krajewska M., Barril G., Scheuermann E.,  Sonkodi S., Goubau P., the HCV Collaborative Group et al., the HCV Collaborative Group.The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study.Nephrol. Dial. Transplant.,2004,19;904
• Weyde W., Badowski R., Krajewska M., Penar J., Moron K., Klinger M..Femoral and iliac vein stenoses after prolonged femoral vein catheter insertion.Nephrol. Dial. Transplant., 2004,19;1618
• Kuzniar J., Marchewka Z., Lembas-Bogaczyk J., Kuzniar T.J., Klinger M. Etiology of increased enzymuria in different morphological forms of glomerulonephritis Nephron Physiol.,2004,98;8
• Vanrenterghem Y., Van Hooff J.P., Klinger M., Wlodarczyk Z., Squifflet J.-P.,  Mourad G., Neuhaus P., Jurewicz A., Rostaing L.,  Charpentier B., Paczek L., Kreis H., Chang R.,  Paul L.C., Grinyo J.M.,  Short C..The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. Transplantation,2004, 78;9
• Szepietowski J., Reich A., Nowicka D. Sun protection in renal transplant recipients: urgent need for education. Dermatology,2005,211;93
• Zaczynska E., Magott-Procelewska M., Rybka K., Siemieniec I., Błach-Olszewska Z., Klinger  M.. Innate antiviral immunity is not impaired in patients with chronic renal failure on hemodialysis. Nephron Clin. Pract.,2005,101;207
• Szepietowski J.C., Reich A., Szepietowski T. Emollients with endocannabinoids in the treatment of uremic pruritus: Discussion of the therapeutic options. Ther. Apher. Dia., 2005,9;277
• Falkiewicz K., Bidzinska B., Demissie M., Boratynska M.,  Zmonarski S.C., Tworowska K., Klinger M., Milewicz A., Patrzałek D.. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Transplant. Proc.,2005,37;1023
• Dorota Kaminska, Bronisław Tyran, Oktawia Mazanowska, et al.. Intragraft mRNA expression of cytokines and growth factors in human kidney allograft biopsies by in situ RT-PCR analysis. Transplant. Proc. 2005 Vol.37 no.2; s.767-769.
• Kaminska D., Tyran B., Mazanowska O., Letachowicz W., Kochman A., Rabczynski J., Szyber P., Patrzałek D.,  Chudoba P.,  Klinger M.. Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis. Transplant. Proc., 2005,37;770
• Vincenti F., Tuncer M., Castagneto M., Klinger M., Friman S.,. Scheuermann E.-H, Wiecek A., Russ G.R.,  Martinek A.,  Nonnast-Daniel B.. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Transplant. Proc., 2005,37;1001
• Zmonarski S.C.,  Boratynska M., Rabczynski J.,  Kazimierczak K., Klinger M.
Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment. Transplant. Proc.,2005,37;964
• Boratynska M., Banasik M., Patrzalek D., Szyber P., Klinger M. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients. Transplant. Proc.,2005,37;839.
• Wlodarczyk Z., Walaszewski J., Perner F., Vitko S., Ostrowski M., Bachleda P., Kokot F., Klinger M.,  Szenohradszky P.,  Studenik P., Navratil P., Asztalos L., Rutkowski B., Kalmar K.N., Hickey D. Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimenns. Transpl. Int., 2005,18;1
• Weyde W., Letachowicz W., Kusztal M., Porażko T., Krajewska M., and Klinger M: Outcome of autogenous fistula construction in hemodialyzed patients over 75 years of age. Blood Purif., 2006, 24, 190-195.
• Kosmaczewska A., Magott-Procelewska M., Frydecka I., Ciszak L., Bocko D., Szteblich A., Kusnierczyk P., Patrzałek D., Szyber P., Klinger M: CD40L, CD28, and CTLA-4 expression on CD4+ T cells in post-transplantation clinical course. Transplant Immunology 2006, 16, 32 - 40.

 

Publications List 2000-2002

1. Boratynska M., Boratynski J., Klinger M., Szyber P., Pawlowski S., Pupka A., Zdrojowy Z., Dembowski J.: Lipid peroxidation and cytokines in chronic allograft failure influence of immunological risk factors. Transplant. Proc., 2000, 32, 1384

2. Boratynska M., Klinger M., Szyber P., Patrzalek D., Polak W.: Interleukin –6 in chronic renal allograft rejection influence of nonimmunologic risk factor. Transplant. Proc.,2001, 33, 1215

3. Boratynska M., Magott M., Klinger M., Smolska D., Myszka K., Szepietowski T., Szyber P., Patrzalek D.: Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss. Transplant. Proc., 2002, 34, 553

4. Boratynska M., Klinger M., Kopec W., Nowakowska B., Banasik M.: Comparison of pretransplant serum alloreactivity estimated by immunoenzymatic assay (PRA-STAT) and lymphocytotoxic test in renal transplant recipients. Transplant. Proc., 2002, 34, 546

5. Falkiewicz K., Kuriata M., Boratynska M, Klinger M., Szepietowski T., Patrzalek D. Szyber P.: Mycophenolate mofetil reduces graft loss due to chronic allograft nephropaty. Transplant Proc., 2002, 34, 567

6. Porazko T., Boratynska M., Patrzalek D., Klinger M., Szyber P.: Causes of death among cadaver kidney graft recipients between 1983 and 2000.Transplant Proc. 2002, 34, 2066

7. Weyde W., Krajewska M., Letachowicz W., Klinger M.: Superficialization of the wrist native arteriovenous fistula for effective hemodialysis vascular access construction. Kidney Int. 2002, 61, 1170

8. Kuriata M., Boratynska M., Klinger M., Wozniak M., Urbaniak J., Szyber P., Patrzalek D., Tupka D.:The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid. Transplant Proc., 2002, 34- in press

Selected abstracts of the present research work:

A. Weyde W., Urbaniak J., Wozniak M., Krajewska M., Mazanowska O., Penar J., Klinger M.: Protein-bound uremic toxins, the comparison of the elimination with urea removal in hemodialysis and continuous ambulatory peritoneal dialysis patients. J. Am. Soc. Nephrol. 2001,12, 350A.

B. Penar J., Urbaniak J., Wozniak M., Krajewska M., Mazanowska O., Weyde W., Klinger M.: The elimination of uremic toxins (p-cresol, indoxyl sulfate, phenol) in comparison to Kt/V and CCr as the indicators of adequancy of chronic ambulatory peritoneal dialysis treatment. Perit. Dial. Int. - 2001, 21, suppl.2, 43

C. Falkiewicz K., Wozniak M., Klinger M., Nahaczewska W., Moron K., Krajewska M., Zmonarski S.C., Owczarek H., Szyber P.: Usefulness of type I collagen plasma markers in patients with osteodystrophy caused by ESRD. Nephrol. Dial. Transpl. - 2001, 1, A23.

D. Weyde W., Badowski R., Krajewska M., Letachowicz W., Moron K., Klinger M.: The influence of prolonged cannulation of the femoral vein on the iliac vein system. Nephrol. Dial. Transpl., 2001, 16, 6, A158

E. Krajewska M., Urbaniak J., Wozniak M., Weyde W., Penar J., Mazanowska O., Klinger M.: Determinants of high homocysteine plasma levels in chronic dialysed patients. Nephrol. Dial. Transpl., 2002, 17,suppl. 1, 256

F. Weyde W., Letachowicz W., Krajewska M., Mazanowska O., Penar J., Rychlewska B., bartosik H., Klinger M.; Abnormalities in radial artery and cephalic vein in ADPKD patients as a cause of difficulties of native arteriovenous fistula creation. Nephrol. Dial. Transpl., 2002, 17,suppl. 1, 282